Drug screening platform using human induced pluripotent stem cell‐derived atrial cardiomyocytes and optical mapping

Current drug development efforts for the treatment of atrial fibrillation are hampered by the fact that many preclinical models have been unsuccessful in reproducing human cardiac physiology and its response to medications. In this study, we demonstrated an approach using human induced pluripotent s...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Stem Cells Transl Med
Main Authors: Gunawan, Marvin G., Sangha, Sarabjit S., Shafaattalab, Sanam, Lin, Eric, Heims‐Waldron, Danielle A., Bezzerides, Vassilios J., Laksman, Zachary, Tibbits, Glen F.
Formato: Artigo
Idioma:Inglês
Publicado: John Wiley & Sons, Inc. 2020
Assuntos:
Cell‐based Drug Development, Screening, and Toxicology
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC7780813/
https://ncbi.nlm.nih.gov/pubmed/32927497
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/sctm.19-0440
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares